Molecular Pathology Procedures
J6 · Effective Oct 1, 2015
9 active Medicare policies list E88.01, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
J6
JK · Effective Oct 1, 2015
JK
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J6 · Effective Feb 12, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
9 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of E88.01 |
|---|---|---|
| Alpha1-Proteinase Inhibitors | Apr 25, 2023 | Covered |
| Lung Denervation Therapy and Lung Volume Reduction Surgery | Mar 16, 2023 | Covered |
| Noninvasive Tests for Hepatic Fibrosis | Feb 20, 2024 | Covered |
| Pulmonary Rehabilitation | Mar 15, 2023 | Covered |
| Tumor Markers | Mar 5, 2024 | Covered |
| Policy | Effective | Status of E88.01 |
|---|
| Concert Genetic Testing: Respiratory | Not recorded | Referenced |
|---|
| Policy | Effective | Status of E88.01 |
|---|---|---|
| Outpatient Alpha-Fetoprotein Testing | Apr 15, 2026 | Covered |
| Policy | Effective | Status of E88.01 |
|---|---|---|
| Flow Cytometry | Sep 15, 2026 | Covered |
| Policy | Effective | Status of E88.01 |
|---|---|---|
| Alpha1-Proteinase Inhibitors | Nov 1, 2025 | Covered |